The DOI matches its Crossref record; 159 of the 165 references it cites were found in a registry or an index.
Etiologic Subtypes of Attention-Deficit/Hyperactivity Disorder: Brain Imaging, Molecular Genetic and Environmental Factors and the Dopamine Hypothesis
Abstract
Multiple theories of Attention-Deficit/Hyper-activity Disorder (ADHD) have been proposed, but one that has stood the test of time is the dopamine deficit theory. We review the narrow literature from recent brain imaging and molecular genetic studies that has improved our understanding of the role of dopamine in manifestation of symptoms of ADHD, performance deficits on neuropsychological tasks, and response to stimulant medication that constitutes the most common treatment of this disorder. First, we consider evidence of the presence of dopamine deficits based on the recent literature that (1) confirms abnormalities in dopamine-modulated frontal-striatal circuits, reflected by size (smaller-than-average components) and function (hypoactivation); (2) clarifies the agonist effects of stimulant medication on dopaminergic mechanisms at the synaptic and circuit level of analysis; and (3) challenges the most-widely accepted ADHD-related neural abnormality in the dopamine system (higher-than-normal dopamine transporter [DAT] density). Second, we discuss possible genetic etiologies of dopamine deficits based on recent molecular genetic literature, including (1) multiple replications that confirm the association of ADHD with candidate genes related to the dopamine receptor D4 (DRD4) and the DAT; (2) replication of differences in performance of neuropsychological tasks as a function of the DRD4 genotype; and (3) multiple genome-wide linkage scans that demonstrate the limitations of this method when applied to complex disorders but implicate additional genes that may contribute to the genetic basis of ADHD. Third, we review possible environmental etiologies of dopamine deficits based on recent studies of (1) toxic substances that may affect the dopamine system in early development and contribute substantially to the etiology of ADHD; (2) fetal adaptations in dopamine systems in response to stress that may alter early development with lasting effects, as proposed by the developmental origins of health and disease hypothesis; and (3) gene-environment interactions that may moderate selective damage or adaptation of dopamine neurons. Based on these reviews, we identify critical issues about etiologic subtypes of ADHD that may involve dopamine, discuss methods that could be used to address these issues, and review old and new theories that may direct research in this area in the future.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This neuromodulatory system is implicated in ADHD (Swanson et al., 2007; Volkow et al., 2009) and may affect both emotional and non-emotional processing.”
From Top-Down Dysregulation—From ADHD to Emotional Instability (2016) · cites this paper as Swanson et al., 2007
In the citing paper
“Regarding the latter, changes in dopaminergic signaling have long been implicated in ADHD ( [48], but see [49])”
From Linking ADHD to the Neural Circuitry of Attention (2017) · cites this paper as [48]
Citations
Cites
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,703
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Lindemann, L., Jaeschke, G., Michalon, A., Vieira, E., Honer, M., Spooren, W., Porter, R., Hartung, T., Kolczewski, S., Büttelmann, B., et al. (1909) · JAMA · doi:10.1001/jama.1909.02550020033007 · Cited by 7,889
The Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355
The American Journal of Human Genetics
S., J. (1950) · Population · doi:10.2307/1523704 · Cited by 5,124
Role of genotype in the cycle of violence in maltreated children
Caspi, A., McClay, J., Moffitt, T. E., Mill, J., Martin, J., Craig, I. W., Taylor, A., & Poulton, R. (2002) · Science · doi:10.1126/science.1072290 · Cited by 4,842
WEIGHT IN INFANCY AND DEATH FROM ISCHAEMIC HEART DISEASE
Barker, D. J. P., Osmond, C., Winter, P. D., Margetts, B., & Simmonds, S. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90710-1 · Cited by 3,574
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
Research works printed but not linked: 4
- Hesse, S., Ballaschkle, O., Barthel, H., von Cramon, D., & Sabri, O. (2006). The striatal dopamine transporter availability is reduced in adults with attention-deficit/hyperactivity disorder. Journal of Nuclear Medicine, 47, 142.
- MTA Cooperative Group. (1999). Multimodal treatment study of children with ADHD. A 140 month randomized clinical trail of treatment strategies for attention deficit/hyperactivity disorder. Archive of General Psychiatry, 56, 1073–1086. · DOI · Paper page
- Nigg, J. T. (2006). What causes ADHD? Toward a multi-path model for understanding what goes wrong and why. New York: Guilford Press.
- Posner, M. I., & Raichle, M. E. (1994). Images of mind. New York: Scientific American Library.
Cited by
Sorted by citations
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Evaluating Dopamine Reward Pathway in ADHD: Clinical Implications
Volkow, N. D., Wang, G.-J., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F., Fowler, J. S., Zhu, W., Logan, J., Ma, Y., et al. (2009) · JAMA · doi:10.1001/jama.2009.1308 · Cited by 728
“The DSM-IV ADHD items were assessed using the Strengths and Weaknesses of ADHD-symptoms and Normal-behavior (SWAN) rating scale, which uses a positive scale for symptoms (1 to 3) and a negative scale for the opposite of the symptoms (−1 to −3) ranging from far belowaverage to faraboveaverage.21 This allowsonetoassess…”
InfluentialSelf-citationChanges in cortical dopamine D1 receptor binding associated with cognitive training
McNab, F., Varrone, A., Farde, L., Jucaite, A., Bystritsky, P., Forssberg, H., & Klingberg, T. (2009) · Science · doi:10.1126/science.1166102 · Cited by 545
The neurobiology and genetics of impulse control disorders: Relationships to drug addictions
Brewer, J. A., & Potenza, M. N. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.043 · Cited by 540
Sonuga-Barke, E., Bitsakou, P., & Thompson, M. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2009.12.018 · Cited by 504
Metadata
- Authors
- Swanson, J. M., Kinsbourne, M., Nigg, J., Lanphear, B., Stefanatos, G. A., Volkow, N., Taylor, E., Casey, B. J., Castellanos, F. X., & Wadhwa, P. D.
- Affiliations
- University of California, Irvine (US)
- The New School (US)
- Michigan State University (US)
- Cincinnati Children's Hospital Medical Center (US)
- Jefferson Einstein Philadelphia Hospital (US)
- Brookhaven National Laboratory (US)
- Cornell University (US)
- New York University (US)
- Corresponding author
- Swanson, James M.
- ORCID
- Venue
- Neuropsychology Review
- Published
- 2007-02-21
- Volume
- 17
- Issue
- 1
- Pages
- 39-59
- ISSN
- 1040-7308 (ISSN-L)
- 1573-6660
- OpenAlex
- W2098273438
- Cited by
- 580
- References
- 165
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 18 · 2023: 26 · 2022: 26 · 2021: 26 · 2020: 24 · 2019: 20 · 2018: 23 · 2017: 27 · 2016: 31 · 2015: 44 · 2014: 37 · 2013: 38 · 2012: 36
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychology Review (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- attention deficit hyperactivity disorder, dopamine transporter, DRD4 gene, stimulant medication response, frontostriatal circuits, genome-wide linkage analysis, environmental etiology, developmental origins of health and disease, gene-environment interaction, prenatal stress, developmental neurotoxicity
- MeSH terms
- Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Brain, Brain Mapping, Dopamine, Humans, Molecular Biology, Nerve Tissue Proteins, Psychological Theory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
